Glaxosmithkline Pharma

Rediff.com » News » Glaxosmithkline Pharma

News for Glaxosmithkline Pharma

Business

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage. Photograph: Kind courtesy Raimond Spekking/CC BY-SA 4.0/wikipedia.org/Creative......

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......

Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

Govt clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

The government on Thursday cleared Rs 6,400-crore (Rs 64-billion) FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. The Cabinet......

How life has changed for India's pharma salesforce

Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and......

Glaxosmithkline Pharma

News for Glaxosmithkline Pharma

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

Domestic pharma market grew by 6.8% in 2023

Govt clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

How life has changed for India's pharma salesforce

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS